Literature DB >> 23296390

Osteoarthritis in 2012: Parallel evolution of OA phenotypes and therapies.

Philip G Conaghan1.   

Abstract

2012 has witnessed new developments in targeted therapies for osteoarthritis, and in ways to identify those patients who might benefit most from their application. Together, these advances could go some way to addressing the urgent need for disease-modifying treatments for this common disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23296390     DOI: 10.1038/nrrheum.2012.225

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


  10 in total

Review 1.  The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis.

Authors:  Jérémie Sellam; Francis Berenbaum
Journal:  Nat Rev Rheumatol       Date:  2010-10-05       Impact factor: 20.543

Review 2.  OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009.

Authors:  W Zhang; G Nuki; R W Moskowitz; S Abramson; R D Altman; N K Arden; S Bierma-Zeinstra; K D Brandt; P Croft; M Doherty; M Dougados; M Hochberg; D J Hunter; K Kwoh; L S Lohmander; P Tugwell
Journal:  Osteoarthritis Cartilage       Date:  2010-02-11       Impact factor: 6.576

3.  In erosive hand osteoarthritis more inflammatory signs on ultrasound are found than in the rest of hand osteoarthritis.

Authors:  Marion C Kortekaas; Wing-Yee Kwok; Monique Reijnierse; Tom W J Huizinga; Margreet Kloppenburg
Journal:  Ann Rheum Dis       Date:  2012-07-20       Impact factor: 19.103

Review 4.  Molecular and biophysical mechanisms regulating hypertrophic differentiation in chondrocytes and mesenchymal stem cells.

Authors:  Deborah Studer; Christopher Millan; Ece Öztürk; Katharina Maniura-Weber; Marcy Zenobi-Wong
Journal:  Eur Cell Mater       Date:  2012-07-24       Impact factor: 3.942

5.  A stem cell-based approach to cartilage repair.

Authors:  Kristen Johnson; Shoutian Zhu; Matthew S Tremblay; Joshua N Payette; Jianing Wang; Laure C Bouchez; Shelly Meeusen; Alana Althage; Charles Y Cho; Xu Wu; Peter G Schultz
Journal:  Science       Date:  2012-04-05       Impact factor: 47.728

6.  Zoledronic acid reduces knee pain and bone marrow lesions over 1 year: a randomised controlled trial.

Authors:  Laura Louise Laslett; Dawn A Doré; Stephen J Quinn; Philippa Boon; Emma Ryan; Tania Maree Winzenberg; Graeme Jones
Journal:  Ann Rheum Dis       Date:  2012-02-21       Impact factor: 19.103

Review 7.  Imaging the painful osteoarthritic knee joint: what have we learned?

Authors:  Claire Y J Wenham; Philip G Conaghan
Journal:  Nat Clin Pract Rheumatol       Date:  2009-03

8.  Prevalence of abnormalities in knees detected by MRI in adults without knee osteoarthritis: population based observational study (Framingham Osteoarthritis Study).

Authors:  Ali Guermazi; Jingbo Niu; Daichi Hayashi; Frank W Roemer; Martin Englund; Tuhina Neogi; Piran Aliabadi; Christine E McLennan; David T Felson
Journal:  BMJ       Date:  2012-08-29

9.  Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification.

Authors:  Gust Verbruggen; Ruth Wittoek; Bert Vander Cruyssen; Dirk Elewaut
Journal:  Ann Rheum Dis       Date:  2011-11-29       Impact factor: 19.103

10.  Targeting tumour necrosis factor alleviates signs and symptoms of inflammatory osteoarthritis of the knee.

Authors:  Walter P Maksymowych; Anthony S Russell; Peter Chiu; Alex Yan; Niall Jones; Tracey Clare; Robert G W Lambert
Journal:  Arthritis Res Ther       Date:  2012-10-04       Impact factor: 5.156

  10 in total
  12 in total

1.  Reflecting on pain management for patients with osteoarthritis and other rheumatic disorders: there's more to pain management than managing pain.

Authors:  Danielle Perret; Eric Y Chang; Winnie Pang; Shuntaro Shinada; Richard S Panush
Journal:  Pain Manag       Date:  2013-07

Review 2.  Proliferative injection therapy for osteoarthritis: a systematic review.

Authors:  Mišo Krstičević; Milka Jerić; Svjetlana Došenović; Antonia Jeličić Kadić; Livia Puljak
Journal:  Int Orthop       Date:  2017-02-11       Impact factor: 3.075

Review 3.  Emerging targets in osteoarthritis therapy.

Authors:  Mary B Goldring; Francis Berenbaum
Journal:  Curr Opin Pharmacol       Date:  2015-04-10       Impact factor: 5.547

Review 4.  Cartilage damage in osteoarthritis and rheumatoid arthritis--two unequal siblings.

Authors:  Thomas Pap; Adelheid Korb-Pap
Journal:  Nat Rev Rheumatol       Date:  2015-07-21       Impact factor: 20.543

5.  The Need for Predictive, Prognostic, Objective and Complementary Blood-Based Biomarkers in Osteoarthritis (OA).

Authors:  Anne-C Bay-Jensen; Yves Henrotin; Morten Karsdal; Ali Mobasheri
Journal:  EBioMedicine       Date:  2016-05-05       Impact factor: 8.143

6.  Mathematical modelling of cytokines, MMPs and fibronectin fragments in osteoarthritic cartilage.

Authors:  Michelle Baker; Bindi S Brook; Markus R Owen
Journal:  J Math Biol       Date:  2017-02-17       Impact factor: 2.259

Review 7.  On the predictive utility of animal models of osteoarthritis.

Authors:  Anne-Marie Malfait; Christopher B Little
Journal:  Arthritis Res Ther       Date:  2015-09-14       Impact factor: 5.156

8.  Biomarkers of (osteo)arthritis.

Authors:  Ali Mobasheri; Yves Henrotin
Journal:  Biomarkers       Date:  2015       Impact factor: 2.658

9.  Injectable nanohydroxyapatite-chitosan-gelatin micro-scaffolds induce regeneration of knee subchondral bone lesions.

Authors:  B Wang; W Liu; D Xing; R Li; C Lv; Y Li; X Yan; Y Ke; Y Xu; Y Du; J Lin
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

10.  Sanguinarine protects against osteoarthritis by suppressing the expression of catabolic proteases.

Authors:  Yan Ma; Xuewu Sun; Kangmao Huang; Shuying Shen; Xianfeng Lin; Ziang Xie; Jiying Wang; Shunwu Fan; Jianjun Ma; Xing Zhao
Journal:  Oncotarget       Date:  2017-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.